Calyxo vs Sub-Q Bionics

Calyxo vs Sub-Q Bionics, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Calyxo is on 55/100 and Sub-Q Bionics on 33/100.

Calyxo logo
CalyxoRedefining kidney stone treatment with an aspiration-based stone removal system.
Try Calyxo
Sub-Q BionicsDeveloping next-generation solutions to improve care for patients living with lymphedema.

Where each one leads

Calyxo

  • our overall score: 55/100 against 33/100
  • funding raised: $151M against $1.5M

Sub-Q Bionics

Leads on none of the measures we hold for both companies.

At a glance

MeasureCalyxoSub-Q Bionics
What it isRedefining kidney stone treatment with an aspiration-based stone removal system.Developing next-generation solutions to improve care for patients living with lymphedema.
CategoryMedical Devices, HealthTech, Biotechnology, MedTechMedical Devices, Biotechnology, HealthTech
Sells toBusiness modelB2BB2B
OfferingHardwareHardware
Founded2016Not published
HeadquartersPleasanton, USAStillwater, USA
StatusActiveActive

Size, funding and growth

MeasureCalyxoSub-Q Bionics
Open roles21Not published
Total funding$151M$1.5M
Latest roundSeries FPre-Seed

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCalyxoSub-Q Bionics
StartupHub scoreOur 0-100 rating55/10033/100
Traction40/10031/100
Search visibility25/10015/100
Quality78/10045/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)Not published
Domain ratingLink authority, 0-10026/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCalyxoSub-Q Bionics
CDNCloudflareNot detected
CMSWordPressNot detected
FrameworksJqueryNot detected
AnalyticsGoogle Tag ManagerNot detected

Calyxo vs Sub-Q Bionics: common questions

Which is better, Calyxo or Sub-Q Bionics?

On our 0-100 score Calyxo rates higher (55/100 against 33/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.

How do Calyxo and Sub-Q Bionics compare on the numbers?

Calyxo leads on our overall score (55/100 against 33/100), funding raised ($151M against $1.5M).

Read the full Calyxo review and pricing or the Sub-Q Bionics review and pricing. You can also browse other Calyxo alternatives we track.